Browse > Article
http://dx.doi.org/10.5012/bkcs.2007.28.9.1535

Transdermal Penetration of Synthetic Peptides and Their Penetration Enhancement Caused by Some Terpene Compounds  

Ham, Seung-Wook (Department of Chemistry, Chung-Ang University)
Kang, Myung-Joo (College of Pharmacy, Chung-Ang University)
Park, Young-Mi (College of Pharmacy, Chung-Ang University)
Oh, Il-Young (College of Pharmacy, Chung-Ang University)
Kim, Bo-Gyun (College of Pharmacy, Chung-Ang University)
Im, Tae-Jong (College of Pharmacy, Chung-Ang University)
Kim, Sung-Hee (College of Pharmacy, Chung-Ang University)
Choi, Young-Wook (College of Pharmacy, Chung-Ang University)
Lee, Jae-Hwi (College of Pharmacy, Chung-Ang University)
Publication Information
Abstract
The work presented in this paper represents a study of the rate and extent of transdermal penetration of three synthetic hexapeptides consisting only of glycine (Gly) and phenylalanine (Phe) as the constituent amino acids and they include Phe-Gly-Gly-Gly-Gly-Gly (Pep-1), Phe-Phe-Gly-Gly-Gly-Gly (Pep-2), and Phe-Phe-Phe- Gly-Gly-Gly (Pep-3). The present study demonstrated the extent to which the peptides having a high metabolic stability were transdermally transported from the various vehicles. The results of this study appear to indicate that minor differences in the lipophilicity of the synthetic hexapeptides have a slight influence on the rate and extent of transport. In the presence of terpene permeation enhancers, together with ethanol (i.e., menthone/ EtOH, carveol/EtOH or cineole/EtOH), the peptides were more rapidly penetrated through the skin and among the terpenes tested, cineole was the most effective for all three peptides. The maximum enhancement ratio of approximately 2 was achieved by cineole in 50% ethanol solution.
Keywords
Transdermal; Synthetic peptide; Permeation enhancer; Terpene;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Donnelly, A.; Kellaway, I. W.; Farr, S. J.; Taylor, G.; Tudball, N.; Gibson, M. Int. J. Pharm. 1996, 135, 191   DOI   ScienceOn
2 Ogiso, T.; Iwaki, M.; Tanino, T.; Nishioka, S.; Higashi, K.; Kamo, M. Biol. Pharm. Bull. 1997, 20, 54   DOI   ScienceOn
3 Magnusson, B. M.; Runn, P.; Karlsson, K.; Koskinen, L.-O. D. Int. J. Pharm. 1997, 157, 113
4 Ganem-Quintanar, A.; Kalia, Y. N.; Falson-Rieg, F.; Buri, P. Int. J. Pharm. 1997, 156, 127
5 Williams, A. C.; Barry, B. W. Crit. Rev. Ther. Drug Carr. Syst. 1992, 9, 305
6 Williams, A. C.; Barry, B. W. Int. J. Pharm. 1991, 74, 157   DOI   ScienceOn
7 Okabe, H.; Takayama, K.; Ogura, A.; Nagai, T. Drug Design Deliv. 1989, 4, 313
8 Pardridge, W. M. Biological Diversity of Peptides; Pardridge, W. M., Ed.; Raven Press: New York, 1991; pp 633-638
9 Yamane, M. A.; Williams, A. C.; Barry, B. W. Int. J. Pharm. 1995, 116, 237   DOI   ScienceOn
10 Franz, T. J.; Tojo, K.; Shah, K. R.; Kydonieus, A. Transdermal Delivery; Kydonieus, A., Ed.; Marcel Dekker Press: New York, 1992; pp 341-421
11 Doyle, M. E.; Greig, N. H.; Holloway, H. W.; Betkey, J. A.; Bernier, M.; Egan, J. M. Endocrinol. 2001, 142, 4462   DOI   ScienceOn